Evidence map›Paper›PMID 41437630›Full record

ArticleJNCI cancer spectrum2026

How to improve the cancer continuum for transgender and gender-diverse patients.

Theodore E Schall, Nfn Scout, Adrian Shanker, Laura E Stamm

Abstract read
In one paragraph

Article in JNCI cancer spectrum, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Theodore E SchallDepartment of Health Promotion and Policy, School of Public Health and Health Sciences, University of Massachusetts Amherst, Amherst, MA, United States.ORCID 0000-0002-0353-2657
Nfn ScoutThe Cancer Network, Providence, RI, United States.ORCID 0000-0001-5485-6152
Adrian ShankerInstitute for Health Policy and Politics, Lehigh University College of Health, Bethlehem, PA, United States.ORCID 0000-0002-6191-7889
Laura E StammDepartment of Medicine, University of Rochester Medical Center, Rochester, NY, United States.ORCID 0009-0003-4865-2972

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transgender and gender-diverse patients experience significant disparities throughout the cancer continuum, including receiving less frequent preventive cancer screenings for all cancer types, being diagnosed with cancer at later stages, and being less likely to receive treatment for some types of cancer. This brief correspondence describes steps that providers and institutions can take to improve research, provider training, and clinical care for this vulnerable population.

Indexed as

Continuity of Patient CareHealthcare DisparitiesNeoplasmsTransgender PersonsEarly Detection of CancerFemaleHealth Services AccessibilityHumansMaleSexual and Gender Minorities

Identifiers

PMID41437630
PMCPMC12803781

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.